ArticleThe Journal of international medical research2026
Impact of sedation with propofol and/or sufentanil on short-term outcomes in patients admitted to the intensive care unit: A retrospective study.
Article in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundIn the intensive care unit, sedation plays a crucial role in managing critically ill patients, particularly those undergoing invasive procedures. Common sedatives such as propofol and sufentanil are administered to ensure comfort and alleviate pain among intensive care unit patients. However, prolonged sedation is associated with risks, including delayed recovery, increased susceptibility to infections, and challenges in monitoring critical conditions. This study investigated the effect of sedation using only propofol, only sufentanil, and a combination of both on short-term outcomes in intensive care unit patients.MethodsIn total, 300 adult intensive care unit patients, both postoperative and nonpostoperative, were included in this retrospective study. The observation period was 10 days from intensive care unit admission. In addition to baseline clinical data, intensive care unit length of stay, delta Sequential Organ Failure Assessment score, occurrence of pulmonary infiltrates on chest X-ray, onset of acute kidney injury, and need for reintubation were assessed as study outcomes.ResultsResults showed that patients sedated using sufentanil alone or in combination with propofol had a longer length of intensive care unit stay and exhibited higher delta Sequential Organ Failure Assessment scores, which worsened over a 10-day period compared with those who were not sedated or administered propofol alone. Additionally, new pulmonary infiltrates occurred more frequently in patients sedated with a combination of propofol and sufentanil than in those who were administered propofol alone or no sedation. Patients who were administered sufentanil alone were reintubated more often than those who were not sedated or were administered propofol alone.ConclusionsThe use of sufentanil, alone or combined with propofol, is associated with poorer short-term outcomes in ICU patients. These findings highlight the need for careful evaluation of sedation strategies in critically ill patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.